Randomized, Double-Blind, Phase III Trial of Ipilimumab Versus Placebo in Asymptomatic or Minimally Symptomatic Patients With Metastatic Chemotherapy-Naive Castration-Resistant Prostate Cancer
T. M. Beer; E. D. Kwon; C. G. Drake; K. Fizazi; C. Logothetis; G. Gravis; V. Ganju; J. Polikoff; F. Saad; P. Humanski; J. M. Piulats; P. Gonzalez Mella; S. S. Ng; D. Jaeger; F. X. Parnis; F. A. Franke; J. Puente; R. Carvajal; L. Sengelov; M. B. McHenry; A. Varma; A. J. van den Eertwegh; W. Gerritsen